WallStSmart
DBVT

DBV Technologies

NASDAQ: DBVT · HEALTHCARE · BIOTECHNOLOGY

$21.00
+3.45% today

Updated 2026-04-30

Market cap
$1.17B
P/E ratio
P/S ratio
207.92x
EPS (TTM)
$-5.25
Dividend yield
52W range
$8 – $26
Volume
0.2M

WallStSmart proprietary scores

22
out of 100
Grade: F
Strong Sell
Investment rating
5.7
Growth
C+
5.0
Quality
C+
2.5
Profitability
F
6.7
Valuation
B
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target
$40.20
+91.43%
12-Month target
Intrinsic (DCF)
$82.86
Margin of safety
+72.73%
1 Strong Buy4 Buy0 Hold1 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Revenue growth 26.20% QoQ
+ 72.73% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-35.20M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$4.80M$15.73M$2.57M$0.00$5.64M
Net income$-96.30M$-72.73M$-113.72M$-147.40M$-44.80M
EPS$-5.25
Free cash flow$-56.45M$-80.33M$-106.81M$-121.71M$-35.20M
Profit margin-2,006.25%-462.40%-4,428.22%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
DBVT$1.17B225.72.56.75.0+72.73%Avoid
LLY$789.69B7810.010.05.06.5Strong Buy
JNJ$547.64B594.79.03.36.0-41.97%Buy
ABBV$351.47B634.08.04.75.0-24.92%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

DBV Technologies trades at $21.00. Our Smart Value Score of 22/100 indicates the stock is weak. TTM revenue stands at $5.64M. Our DCF model estimates intrinsic value at $82.86.

Frequently asked questions

What is DBV Technologies's stock price?
DBV Technologies (DBVT) trades at $21.00.
Is DBV Technologies overvalued?
Smart Value Score 22/100 (Grade F, Strong Sell). DCF value $82.86.
What is the price target of DBV Technologies (DBVT)?
The analyst target price is $40.20, representing +91.4% upside from the current price of $21.00.
What is the intrinsic value of DBV Technologies (DBVT)?
Based on our DCF model, intrinsic value is $82.86, a +72.7% margin of safety versus $21.00.
What is DBV Technologies's revenue?
TTM revenue is $5.64M.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio207.92x
ROE-149.80%
Beta-0.20
50D MA$20.91
200D MA$15.92
Shares out0.06B
Float0.17B
Short ratio
Avg volume0.2M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years